Stocks Fall After Dow, S&P Hit Record

U.S. stocks opened lower Tuesday, signaling that major benchmarks will pare back gains a day after they closed at record highs.

The Dow Jones Industrial Average fell 1.3%, about 370 points lower. The blue-chips index on Monday rose to an all- time high and closed just short of the 30000-point milestone level.

The S&P 500 slid 0.9%. Investors are likely taking a breather to lock in profits after sending the broad market gauge to its second consecutive record close on optimism about new Covid-19 vaccines. The tech-heavy Nasdaq Composite Index fell 0.4%.

Fresh data Tuesday showed that retail sales rose 0.3% in October, with the pace of growth slowing considerably amid rising coronavirus cases and uncertainty ahead of the U.S. presidential election. Industrial production rose 1.1% in October, but output for the month was still 5.6% lower than its pre-pandemic February level.

Tesla soared 12% as investors prepared for the electric-car maker to be added to the S&P 500 index on Dec. 21. The move is expected to galvanize the company's bullish investors, who had already propelled its stock up roughly 480% this year.

Walgreens Boots Alliance tumbled 8% after Amazon.com said it is launching a rival online pharmacy. CVS Health dropped more than 7%.

Investors renewed bets at the start of the week that the economy is likely to stage a sharp recovery from the coronavirus pandemic in 2021 after Moderna's experimental vaccine proved 94.5% effective at protecting people from Covid-19.

"There is still plenty of wind out there. It's just a question of getting the sails right in order to catch it," said Peter Dixon, senior economist at Commerzbank. "There's always going to be the sense that the initial burst of enthusiasm is followed by a little bit of retrenchment."

In contrast to the broader market's slide, many technology stocks were more resilient Tuesday.

"If you look at the world today, specifically the developed world today, growth is going to be difficult to come by," said Randeep Somel, fund manager at M & G Investments. Technology companies "are enough of a disruptive force to take away business from existing companies, existing sectors, existing industries, without having to have the wider market -- GDP plus 2-3% -- to grow in order to see that."

For the broader market, optimism about economic prospects once vaccines are rolled out is being tempered by more immediate concerns surrounding soaring coronavirus infections and hospitalizations.

The number of newly reported Covid-19 cases in the U.S. jumped on Monday to over 166,000 cases from a day earlier, and the number of those hospitalized hit another record. Local authorities across the country are imposing fresh restrictions on social activity to curb the outbreak, which could hobble the economy in the winter months.

"Attention might be drawn from the light at the end of the tunnel back toward some of the short-term difficulties," said Paul O'Connor, head of the U.K.-based multiasset team at Janus Henderson Investors. "The data on the coronavirus front are looking really troublesome in the U.S., the virus is surging across the U.S."

The yield on 10-year U.S. Treasury notes slid to 0.872%, from 0.906% Monday.

Overseas, the pan-continental Stoxx Europe 600 index ticked down 0.6%, led lower by the U.K.'s largest stocks.

Most major Asian equity benchmarks ended the day with muted gains. Japan's Nikkei 225 index rose 0.4%, while Hong Kong's Hang Seng Index ticked up 0.1%. China's Shanghai Composite Index fell 0.2%.

Write to Jem Bartholomew at jem.bartholomew@wsj.com


  (END) Dow Jones Newswires
  11-17-20 1010ET
  Copyright (c) 2020 Dow Jones & Company, Inc.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.